BlossomHill Therapeutics, Inc.

We’re #hiring a new Senior/Executive Director, Clinical Pharmacology in San Diego County, California. Apply today or share this post with your network.

We are thrilled to be planning our next move into this cutting-edge Torrey Pines biotech hub in #SanDiego, made possible by the team at BioMed Realty. This space will be the new home office where we will continue to pursue our mission to address unmet medical needs in #oncology and #autoimmune disorders. Stay tuned as we continue to grow our team and push the boundaries of scientific innovation to improve patient lives!

We are proud to share that our President and CEO Dr. J. Jean Cui was recognized as one of the 11 Asian American executives shaping the future of biopharma by the Timmerman Report. This accolade further underscores Jean’s outstanding leadership, vision, and unwavering dedication to advancing medical innovation for the benefit of patients. View the full list here: https://bit.ly/3VuEK8r

We are thrilled to see our CEO, Dr. J. Jean Cui, featured in The Medicine Maker 2024 Power List! Her leadership and groundbreaking research have brought several cutting-edge medicines to patients in need. Join us in congratulating Dr. Cui on this prestigious recognition that underscores her commitment to developing medicines that make a difference in patients’ lives. More here: https://bit.ly/3Jm09K4

We’re looking forward to presenting at #AACR24! Don’t miss our poster presentations featuring preclinical data from our CLK inhibitor program. See more details below and view our abstracts here: https://bit.ly/3xkGmYM and https://bit.ly/49gHCJI American Association for Cancer Research

#ICYMI Matthew Herper of STAT sat down with our CEO, Dr. J. Jean Cui, to learn more about her story and mission to develop effective therapeutics that tackle drug resistance. Discover how Dr. Cui and BlossomHill are applying human intelligence and creativity to drug design with the goal of extending survival and improving quality of life for #cancer patients. Read the full article here: https://bit.ly/49NRCLA     #precisionmedicine  

Our CEO, Dr. J. Jean Cui, connected with BiotechTV’s Brad Loncar following our completion of a $100 million financing to gain insight into Dr. Cui’s perspective on #precisionmedicines and how we are working to solve unmet medical needs by re-envisioning #cancer drug development. Watch the full video here: https://bit.ly/3Isffxy

We’re proud to announce the completion of a $100 million financing round to support us in making a leap forward and advancing our pipeline for the treatment of #cancer and #autoimmune diseases. Learn more about the news and our commitment to redefining #precisionmedicine: https://lnkd.in/euNFdMfy   #Financing #Biotechnology 

#ICYMI: Our President and CEO, Dr. J. Jean Cui, was recently elected to the National Academy of Engineering (NAE) for her innovation of new medicines to fight cancers and address urgent medical needs. Election to the NAE is among the highest professional distinctions accorded to an engineer and recognizes outstanding contributions to #engineering research and practice. Congratulations, Dr. Cui! More here: https://bit.ly/3wjDo6A #NAE2024